Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption

被引:226
作者
Zou, Wei
Kitaura, Hideki
Reeve, Jennifer
Long, Fanxin
Tybulewicz, Victor L. J.
Shattil, Sanford J.
Ginsberg, Mark H.
Ross, F. Patrick
Teitelbaum, Steven L. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[4] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England
[5] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
基金
英国医学研究理事会;
关键词
D O I
10.1083/jcb.200611083
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, we establish that the tyrosine kinase Syk is essential for osteoclast function in vitro and in vivo. Syk(-/-) osteoclasts fail to organize their cytoskeleton, and, as such, their bone-resorptive capacity is arrested. This defect results in increased skeletal mass in Syk-/embryos and dampened basal and stimulated bone resorption in chimeric mice whose osteoclasts lack the kinase. The skeletal impact of Syk deficiency reflects diminished activity of the mature osteoclast and not impaired differentiation. Syk regulates bone resorption by its inclusion with the alpha v beta 3 integrin and c-Src in a signaling complex, which is generated only when alpha v beta 3 is activated. Upon integrin occupancy, c-Src phosphorylates Syk. alpha v beta 3-induced phosphorylation of Syk and the latter's capacity to associate with c-Src is mediated by the immunoreceptor tyrosine-based activation motif (ITAM) proteins Dap12 and FcR gamma. Thus, in conjunction with ITAM-bearing proteins, Syk, c-Src, and alpha v beta 3 represent an essential signaling complex in the bone-resorbing osteoclast, and, therefore, each is a candidate therapeutic target.
引用
收藏
页码:877 / 888
页数:12
相关论文
共 30 条
[1]   Specification of the direction of adhesive signaling by the integrin β cytoplasmic domain [J].
Arias-Salgado, EG ;
Lizano, S ;
Shattil, SJ ;
Ginsberg, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (33) :29699-29707
[2]   Src kinase activation by direct interaction with the integrin β cytoplasmic domain [J].
Arias-Salgado, EG ;
Lizano, S ;
Sarkar, S ;
Brugge, JS ;
Ginsberg, MH ;
Shattil, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13298-13302
[3]   REQUIREMENT OF PP60C-SRC EXPRESSION FOR OSTEOCLASTS TO FORM RUFFLED BORDERS AND RESORB BONE IN MICE [J].
BOYCE, BF ;
YONEDA, T ;
LOWE, C ;
SORIANO, P ;
MUNDY, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1622-1627
[4]   Intramolecular regulatory switch in ZAP-70: Analogy with receptor tyrosine kinases [J].
Brdicka, T ;
Kadlecek, TA ;
Roose, JP ;
Pastuszak, AW ;
Weiss, A .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (12) :4924-4933
[5]   Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by β3 integrin [J].
Faccio, R ;
Novack, DV ;
Zallone, A ;
Ross, FP ;
Teitelbaum, SL .
JOURNAL OF CELL BIOLOGY, 2003, 162 (03) :499-509
[6]   c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation [J].
Faccio, R ;
Takeshita, S ;
Zallone, A ;
Ross, FP ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :749-758
[7]   High dose M-CSF partially rescues the Dap12-/-osteoclast phenotype [J].
Faccio, R ;
Zou, W ;
Colaianni, G ;
Teitelbaum, SL ;
Ross, FP .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (05) :871-883
[8]   Vav3 regulates osteoclast function and bone mass [J].
Faccio, R ;
Teitelbaum, SL ;
Fujikawa, K ;
Chappel, J ;
Zallone, A ;
Tybulewicz, VL ;
Ross, FP ;
Swat, W .
NATURE MEDICINE, 2005, 11 (03) :284-290
[9]   A Glanzmann's mutation in β3 integrin specifically impairs osteoclast function [J].
Feng, X ;
Novack, DV ;
Faccio, R ;
Ory, DS ;
Aya, K ;
Boyer, MI ;
McHugh, KP ;
Ross, FP ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1137-1144
[10]   Structural basis for syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide [J].
Fütterer, K ;
Wong, J ;
Grucza, RA ;
Chan, AC ;
Waksman, G .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 281 (03) :523-537